Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)

This study has been completed.

Study NCT00050154 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: November 22, 2002 Last Updated: November 20, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2006
Estimated Primary Completion Date:	No date given